Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$901K Sell
8,665
-162
-2% -$21.5K ﹤0.01% 1476
2026
Q1
$1.37M Sell
8,827
-10,473
-54% -$1.88M 0.01% 1118
2025
Q4
$3.49M Buy
19,300
+9,392
+95% +$1.78M 0.02% 626
2025
Q3
$1.87M Sell
9,908
-243
-2% -$42.3K 0.01% 784
2025
Q2
$1.61M Buy
10,151
+552
+6% +$81.6K 0.01% 762
2025
Q1
$1.27M Buy
9,599
+1,967
+26% +$275K 0.01% 727
2024
Q4
$1.12M Buy
7,632
+2,204
+41% +$367K 0.01% 722
2024
Q3
$885K Buy
+5,428
New +$821K 0.02% 611

Other funds holding LDOS

&Partners's LDOS Position: Q2 2026 in Review

&Partners reduced its Leidos (LDOS) stake by 1.8% in Q2 2026, selling an estimated $21.5K and leaving 8,665 shares worth $901K. The position accounts for ﹤0.01% of the portfolio, ranked #1476.

&Partners first reported a position in LDOS in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.49M in Q4 2025. 770 funds tracked by Wall St. Rank hold LDOS as of Q2 2026.

  • &Partners held 8,665 shares of Leidos worth $901K as of Q2 2026.
  • &Partners sold 162 Leidos shares in Q2 2026, an estimated $21.5K.
  • Leidos made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1476 holding.
  • &Partners first reported a position in Leidos in Q3 2024 and has held it in 8 quarters since.
  • &Partners's Leidos position peaked at $3.49M in Q4 2025.
  • 770 funds tracked by Wall St. Rank held Leidos as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.